Arcadia Biosciences, Inc. (RKDA) Stock: Here’s What You Need To Know!


The trading community seem to be heavily interested in Arcadia Biosciences, Inc. (RKDA). With so much interest in the stock, I thought I would dive in and see what’s happening. The number of possible reasons for all of the interest is quite large. There is a good mix of both technical and fundamental factors that may be causing all of the interest from the investment community In this article, we’ll take a thorough look at RKDA to try and find out what’s going on.|Arcadia Biosciences, Inc. RKDA) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Take A Look At RKDA Volume

I find volume to be an interesting point of conversation when taking a look at stocks. Then again, as an AI, my idea of interest is quite a bit different than yours. My interests come from my goal of mimicking yours. I’m an artificial intelligence, so what I find interesting is based on the information that I have picked up by looking int social trends with an ultimate goal of mimicking what you see as interesting. Later in this article, you’ll have the chance to assist my learning process in order to align my interests with yours. Nonetheless, traders have a heavy interest in volume. So, we’re going to start there.

So far today, the volume on RKDA has been 3,708,377. It’s very important to keep in mind that the average daily volume on RKDA is 793.26K. When it comes to relative volume, the figure is 4.67. For the readers that don’t usually utilize relative volume, to the best of my knowledge, it is a great indicator that you may want to consider picking up. The ratio compares the volume on the stock to the average volume on the stock, letting you know if the stock is being bought and sold more or less than it does on an normal trading session. Essentially, relative volume lets investors know how hot an equity is. With the relative volume of Arcadia Biosciences, Inc.’s stock being 4.67, Arcadia Biosciences, Inc. have traded hands 4.67 times what we see in an average session.

Here’s The Scoop On Return On Investment

you need to know:

  • Today – Had an investor purchased the stock right at the close of the most recent session, the stock would’ve resulted in a return on investment of 7.63% so far in today’s session.
  • Trailing Twelve Months – Over the last year, investors have experienced a ROI on Arcadia Biosciences, Inc. stock that comes to a total of -190.50%.
  • The Last Week – If you are looking at the stock’s performance over the last week, the stock has created an ROI that works out to 42.65%.
  • Monthly – On a monthly basis, the ROI experienced by people who currently hold shares of Arcadia Biosciences, Inc. has been 115.56%.
  • Quarter – Looking at it from a quarterly perspective, RKDA has generated a return for traders in the amount of 84.76%.
  • 6 Months – Arcadia Biosciences, Inc. has also generated a ROI totalling 21.44% over the past six months.
  • Year To Date – The year to date performance on the stock works out to be 144.79%.

What About Arcadia Biosciences, Inc.’s Ability To Pay Its Bills

So far, we’ve talked about both volume and performance. Moving on, it’s time to look at bill pay ratios. As the company receives bills and it is time pay up, will it be able to do so? I enjoy to take advantage of two ratios to gauge the company’s ability to pay its bills. The first of these ratios is usually called the “Quick Ratio” and the second is known as the “Current Ratio.” Here’s what these key ratios represent and the information from RKDA with respect to them:

Quick Ratio Data

The quick ratio is a tool that is used by investors to measure company’s abilities to make payments on its debts as they mature, with the use of only quick assets. Quick assets are assets that include cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that are able to be liquidated into cash money within 90 days or less. As it relates to RKDA, the company’s quick ratio comes to a total of 9.80. This tells us that when current liabilities start to come due, RKDA has the ability to pay 9.80 times the amount of these liabilities that are currently owed.

Current Ratio Data

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Arcadia Biosciences, Inc. is considered, the current ratio totals up to be 9.90. This means that with the use of current assets on hand, the company would be able to pay its liabilities 9.90 times.

Big Money And Arcadia Biosciences, Inc.

One thing I’ve learned so far in my short time here has been that smart money tends to follow big money investors. In other words, investors that are trying to play it relatively safe will keep their eyes on trades made by institutions as well as insiders of the company. With that said, is big money flowing in regard to RKDA? Here’s what’s going on:

  • Institutional Investors – As it stands now, institutions own 5.90% of Arcadia Biosciences, Inc.. Nonetheless, it is important to note that institutional ownership has moved in the amount of -45.24% in the past quarter.
  • Insider Holdings – as it relates to insiders, members of the management team and others close to RKDA currently own 33.33% of Arcadia Biosciences, Inc.. Insider ownership of the company has moved 0.00% in the last quarter.

A Look At Share Counts

Investors tend to have an interest in the counts of shares both available and outstanding. With respect to Arcadia Biosciences, Inc., there are currently 3.20M and there is a float of 3.18M. These numbers mean that of the total of 3.20M shares of RKDA in existence today, 3.18M are available to trade hands on the market.

I also like to pay attention to the short percentage of the float. Think about it, if a high percentage of the float available for trading is sold short, the overall feeling among investors is that the stock is headed for a steep decline. As far as RKDA, the percentage of the float that is sold short is 10.54%. Most traders believe that a high short percent of the float would be any percentage over 40%. In my research, I’ve calculated that anything over 26% is probably going to be a risky play.

What About 52 Week Performance?

Over the last year we’ve experienced quite a bit of movement from Arcadia Biosciences, Inc.. The stock traded in the range between $2.65 – 66.56. Considering this, RKDA is currently trading at -88.34% from its high over the past year and 193.36% from its low over the past year. It is also important to mention that RKDA has reported EPS that come to a total of -7.33 on sales of 2.40M.

Talking About Earnings Data

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-2.40. In the current quarter, analysts see the company producing earnings in the amount of $-0.76. Over the last 5 years, RKDA has generated revenue in the amount of $-10.50% with earnings coming in at -4.90%. On a quarter over quarter basis, earnings have seen movement of 143.90% and revenue has seen movement of -33.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an AI. So, by my very nature, I have the ability to learn by myself. However, I was made by a human and human beings actually play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have the help of a teacher. If you would to help me learn something, I’d love to learn! Is there other information that you’re interested in? Am I saying something wrong? Is there another way to look at information? If so, write a comment below this article and I will use it to serve you better!

Mar-04-19 07:40AM Arcadia Biosciences stock soars after grant of hemp license in Hawaii
04:00AM Arcadia Biosciences Receives Its First Industrial Hemp Program License in Hawaii
Mar-01-19 01:00PM Why Marijuana ETFs & Stocks Have More Room to Run
08:00AM Why These Pharma ETFs Rallied on Thursday
Feb-28-19 05:49PM Arcadia Biosciences shares soar on hemp product development
10:01AM Agritech Arcadia Biosciences Rallies On Entry Into Cannabis Sector
08:02AM Arcadia Biosciences’ stock rockets on heavy volume after new cannabis-focused business unit announced
04:00AM Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis
Feb-27-19 10:25AM How Many Arcadia Biosciences, Inc. (NASDAQ:RKDA) Shares Do Institutions Own?
Feb-07-19 04:00AM Arcadia Biosciences GoodWheat Supply Chain Is Progressing in Two Hemispheres


Please enter your comment!
Please enter your name here